Form 4 for PCVX Vaxcyte, Inc.
Accepted 2024-04-19 00:00:00 ET · period of report 2024-04-17 · accession 0001415889-24-011233 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-19 | 2024-04-17 | PCVX | Wassil Jim | COO | M - OptEx | $5.35 | +3,551 | 221.8K | +2% | +$19.0K |
| D | 2024-04-19 | 2024-04-17 | PCVX | Wassil Jim | COO | M - OptEx | $0.00 | -3,551 | 78.6K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-17 | M | A | 3,551 | $5.35 | 221,840 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2024-04-17 | M | D | 3,551 | $0.00 | 78,611 | D | $5.35 · — to 2030-04-17 | 3,551 Common Stock | (F1) Stock Option is fully vested and exercisable. |